CLINICAL_TRIALS
trial_result
· 2021-04-15
Clinical Trial Update: Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain [Phase 3]
Summary
Phase 3 trial assessing subdissociative dose ketamine for acute pain in adults with chronic pain completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Chronic Pain | Phase 3 | Status: COMPLETED | Results posted: 2021-04-15